It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • PRINT SUBSCRIBERS |
  • SUBSCRIBE |
  • Login
  • My Account
weather icon

26

M/SUNNY

TOKYO (11 a.m.)

TODAY'S PRINT EDITION

The Japan Times The Japan Times

Johnson & Johnson

  • Login
  • SUBSCRIBE
  • My Account
  • PRINT SUBSCRIBERS ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
U.S. authorizes Johnson & Johnson's COVID-19 vaccine

World Feb 28, 2021

U.S. authorizes Johnson & Johnson's COVID-19 vaccine

J&J's vaccine is expected to be used widely around the globe because it can be shipped and stored at normal refrigerator temperatures, making distribution easier.

Johnson & Johnson’s vaccine advances, sparking optimism in race

World / Science & Health Sep 24, 2020

Johnson & Johnson’s vaccine advances, sparking optimism in race

by Carl Zimmer and Katie Thomas

The company's vaccine could require just one shot instead of two — important considering that the entire population of the world needs vaccination.

Japan in talks with Johnson & Johnson to secure COVID-19 vaccine

Business / Corporate Jul 17, 2020

Japan in talks with Johnson & Johnson to secure COVID-19 vaccine

The company has already agreed to prioritize an allocation to the United States as part of a funding agreement, according to the firm's chief financial officer.

Firms sign deals with U.S. to prep for mass-producing virus vaccines

Business / Corporate Mar 31, 2020

Firms sign deals with U.S. to prep for mass-producing virus vaccines

The U.S. government has cut deals with Johnson & Johnson and Moderna Inc. and said it is in talks with at least two other companies to prepare them to produce massive quantities of coronavirus vaccines even before safe and effective ones become available. There are ...

J&J CEO says he didn't read internal documents on possible asbestos in Baby Powder

Business Jan 28, 2020

J&J CEO says he didn't read internal documents on possible asbestos in Baby Powder

Johnson & Johnson Chief Executive Alex Gorsky told a jury Monday that he did not read all the internal company documents related to potential asbestos contamination in Johnson's Baby Powder. It was the CEO's first appearance in a jury trial over allegations that the company's ...

Largest study yet offers no clear talc link to ovarian cancer

World / Science & Health Jan 8, 2020

Largest study yet offers no clear talc link to ovarian cancer

U.S. researchers who conducted the largest study yet into whether applying powder to the genitals increases a woman's risk of ovarian cancer were unable to definitively put to rest the issue that has prompted thousands of lawsuits against Johnson & Johnson and other companies. Overall, ...

U.S. opioid ruling gives 'green light' for other lawsuits

World / Science & Health Aug 27, 2019

U.S. opioid ruling gives 'green light' for other lawsuits

While some Johnson & Johnson investors were relieved that the company's $572 million penalty for fueling Oklahoma's opioid epidemic wasn't as high as feared, lawyers for other U.S. states, cities and counties could hardly contain their glee. That's because the ruling by Oklahoma Judge Thad ...

Congo health minister's resignation over Ebola snub could unblock new vaccine

World / Science & Health Jul 23, 2019

Congo health minister's resignation over Ebola snub could unblock new vaccine

Congo's health minister resigned on Monday after being stripped of responsibility for managing the country's Ebola outbreak, potentially paving the way for the introduction of a second vaccine to contain the spreading epidemic. Oly Ilunga has overseen Congo's near year-long response to what is the ...

U.S. giant Johnson & Johnson makes $2.1 billion offer to buy out Japan cosmetics firm Ci:z

Business / Corporate Oct 24, 2018

U.S. giant Johnson & Johnson makes $2.1 billion offer to buy out Japan cosmetics firm Ci:z

U.S. health care conglomerate Johnson & Johnson said on Tuesday it will buy all outstanding shares of Japanese skin care firm Ci:z Holdings Co. that it does not already own for ¥230 billion ($2.05 billion) in cash. J&J is betting the deal — which will ...

Missouri jury orders Johnson & Johnson to pay over $4 billion to 22 women who allege its talc caused cancer, contained asbestos

Business Jul 13, 2018

Missouri jury orders Johnson & Johnson to pay over $4 billion to 22 women who allege its talc caused cancer, contained asbestos

A Missouri jury on Thursday ordered Johnson & Johnson to pay a record $4.69 billion to 22 women who alleged the company's talc-based products, including its baby powder, contain asbestos and caused them to develop ovarian cancer. The verdict is the largest the firm has ...

Business Nov 17, 2017

Federal jury orders J&J, DePuy to pay $247 million to six Pinnacle hip implant patients

A federal jury in Dallas on Thursday ordered Johnson & Johnson and its DePuy Orthopaedics unit to pay $247 million to six patients who said they were injured by defective Pinnacle hip implants. Delivering the third straight win to patients against the companies, the jury ...

« 1 2
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Fight or surrender: Taiwan’s generational divide on China’s threats
    Huang Hsuan-yuan, 2, with her mother Chang I-chieh, who thinks that Taiwan's freedom and democracy are paramount.
  • Japan government to fight damages suit filed by kin of dead Sri Lankan
    A crowd in Tokyo marches to demand improved treatment in Japan's detention centers on March 6, the anniversary of the death of Sri Lankan detainee Ratnayake Liyanage Wishma Sandamali.
  • Japan to roll out COVID vaccine that targets omicron as early as October
    A local resident receives a COVID-19 booster shot at a mass vaccination center in Tokyo. Japan plans to roll out a new type of COVID-19 vaccine considered effective against the omicron variant as early as October.
  • What will it take for Japan to embrace plant-based meat?
    Japan’s plant-based meat industry is expected to see phenomenal growth over the next few years.
  • What it would mean for Japan to downgrade its COVID classification
    A nurse tests a child for COVID-19 at a makeshift "fever clinic" outside a pediatric clinic in Fukuoka on Thursday.
  • More Chinese women delay or give up on having babies after 'COVID zero' ordeal

    Thumbnail image
  • U.S. revamps sub-Saharan Africa strategy amid growing Chinese and Russian influence

    Thumbnail image
  • What it would mean for Japan to downgrade its COVID classification

    Thumbnail image
  • Kishida Cabinet’s approval rating falls as headwinds mount

    Thumbnail image
  • Political newcomer Sanseito making waves in Okinawa elections

    Thumbnail image

PODCAST

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha Study in Japan JT for Women JT Bookclub Japanese School Directory The Japan Times Jobs
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link Policy
  • Reprints
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times